Here authors show that inactivation of the tumor suppressors NF1, TSC1, and TGF-β RII also promotes a non-cell autonomous change in the tumor microenvironment, characterized by inflammatory features and LAG3+ T cell-mediated immune suppression, which are therapeutically targetable. This evidence concerns the gene TSC1 and neoplasm.